Chosing clopidogrel as a preferred ADP receptor blocker in primary percutaneous coronary intervention. Patient profile and predictors of use.
15 October 2016 (00:00 - 00:00)
Organised by:
About the speaker
Clinical University Hospital Lozano Blesa, Zaragoza (Spain)
21 More presentations in this session
Doctor Y. Fakhri (Roskilde, DK)
Doctor B. Narziev (Tashkent, UZ)
Professor S. Aguiar (Lisbon, PT)
Doctor D. Carvalho Silva (Faro, PT)
Doctor E. Figueiredo (Belo Horizonte, BR)
Access the full session
The Event
Acute Cardiovascular Care 2016
15 October - 17 October 2016
